624 related articles for article (PubMed ID: 25493013)
21. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.
Cekaite L; Eide PW; Lind GE; Skotheim RI; Lothe RA
Oncotarget; 2016 Feb; 7(6):6476-505. PubMed ID: 26623728
[TBL] [Abstract][Full Text] [Related]
23. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.
Iida M; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Tokumitsu Y; Tomochika S; Tokuhisa Y; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Fujita K; Kuroda M; Nagano H
Oncol Rep; 2018 Sep; 40(3):1621-1631. PubMed ID: 30015977
[TBL] [Abstract][Full Text] [Related]
25. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
26. The significance of DNA methylation profile in metastasis-related genes for the progression of colorectal cancer.
Tokarz P; Pawlowska E; Bialkowska-Warzecha J; Blasiak J
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):79-87. PubMed ID: 28364795
[TBL] [Abstract][Full Text] [Related]
27. The role of microRNAs in colorectal liver metastasis: Important participants and potential clinical significances.
Wang D; Liu J; Huo T; Tian Y; Zhao L
Tumour Biol; 2017 Jun; 39(6):1010428317709640. PubMed ID: 28651498
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis.
D'Angelo E; Vicentini C; Agostini M; Kiss A; Baffa R; Scarpa A; Fassan M
Curr Drug Targets; 2015; 16(4):383-92. PubMed ID: 25495924
[TBL] [Abstract][Full Text] [Related]
29. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
Valeri N; Croce CM; Fabbri M
Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
[TBL] [Abstract][Full Text] [Related]
30. The role of microRNAs in colorectal cancer.
Mohammadi A; Mansoori B; Baradaran B
Biomed Pharmacother; 2016 Dec; 84():705-713. PubMed ID: 27701052
[TBL] [Abstract][Full Text] [Related]
31. An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.
Weng W; Feng J; Qin H; Ma Y; Goel A
Future Oncol; 2015; 11(12):1791-808. PubMed ID: 26075447
[TBL] [Abstract][Full Text] [Related]
32. Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics.
Kou Y; Qiao L; Wang Q
Tumour Biol; 2015 Apr; 36(4):2249-55. PubMed ID: 25412953
[TBL] [Abstract][Full Text] [Related]
33. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
34. Identifying metastasis-initiating miRNA-target regulations of colorectal cancer from expressional changes in primary tumors.
Lee J; Hong HK; Peng SB; Kim TW; Lee WY; Yun SH; Kim HC; Liu J; Ebert PJ; Aggarwal A; Jung S; Cho YB
Sci Rep; 2020 Sep; 10(1):14919. PubMed ID: 32913235
[TBL] [Abstract][Full Text] [Related]
35. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.
Rahmani F; Avan A; Hashemy SI; Hassanian SM
J Cell Physiol; 2018 Feb; 233(2):811-817. PubMed ID: 28266708
[TBL] [Abstract][Full Text] [Related]
36. From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer.
Mohammed OA
Pathol Res Pract; 2023 Nov; 251():154857. PubMed ID: 37804545
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
38. Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.
Chorti A; Bangeas P; Papavramidis TS; Tsoulfas G
Microrna; 2018; 7(3):167-177. PubMed ID: 29793419
[TBL] [Abstract][Full Text] [Related]
39. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy.
Yang Y; Meng WJ; Wang ZQ
Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1211-1226. PubMed ID: 32370729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
